» Articles » PMID: 15240881

Template-assisted Filament Growth by Parallel Stacking of Tau

Overview
Specialty Science
Date 2004 Jul 9
PMID 15240881
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Tau filaments are found in >20 neurodegenerative diseases. Yet, because of their enormous molecular weights and poor tendency to form highly ordered 3D crystal lattices, they have evaded high-resolution structure determination. Here, we studied 25 derivatized tau mutants by using electron paramagnetic resonance and fluorescence spectroscopy to report structural details of tau filaments. Based on strong spin exchange and pyrene excimer formation of core residues, we find that individual tau proteins form single molecule layers along the fiber axis that perfectly stack on top of each other by in-register, parallel alignment of beta-strands. We suggest a model of filament growth wherein the existing filament serves as a template for the incoming, unfolded tau molecule, resulting in a new structured layer with maximized hydrogen-bonded contact surface and side-chain stacking.

Citing Articles

Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers.

Jamerlan A, Shim K, Sharma N, An S Int J Mol Sci. 2025; 26(3).

PMID: 39940966 PMC: 11818661. DOI: 10.3390/ijms26031199.


Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities.

Cascio F, Park S, Sengupta U, Puangmalai N, Bhatt N, Shchankin N Commun Biol. 2025; 8(1):53.

PMID: 39809992 PMC: 11733013. DOI: 10.1038/s42003-025-07499-w.


Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers.

Krzesinski B, Holub T, Gabani Z, Margittai M ACS Chem Neurosci. 2024; 16(2):171-180.

PMID: 39714208 PMC: 11740991. DOI: 10.1021/acschemneuro.4c00607.


MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross-seeding ability.

Bhopatkar A, Bhatt N, Haque M, Xavier R, Fung L, Jerez C Protein Sci. 2024; 33(9):e5099.

PMID: 39145409 PMC: 11325167. DOI: 10.1002/pro.5099.


Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In Vivo.

Sengupta U, Kayed R Methods Mol Biol. 2024; 2754:147-183.

PMID: 38512666 DOI: 10.1007/978-1-0716-3629-9_9.


References
1.
King M, Ahuja V, Binder L, Kuret J . Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry. 1999; 38(45):14851-9. DOI: 10.1021/bi9911839. View

2.
Cleveland D, Hwo S, Kirschner M . Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol. 1977; 116(2):227-47. DOI: 10.1016/0022-2836(77)90214-5. View

3.
Langen R, Oh K, Cascio D, Hubbell W . Crystal structures of spin labeled T4 lysozyme mutants: implications for the interpretation of EPR spectra in terms of structure. Biochemistry. 2000; 39(29):8396-405. DOI: 10.1021/bi000604f. View

4.
Hubbell W, Cafiso D, Altenbach C . Identifying conformational changes with site-directed spin labeling. Nat Struct Biol. 2000; 7(9):735-9. DOI: 10.1038/78956. View

5.
Abraha A, Ghoshal N, Gamblin T, Cryns V, Berry R, Kuret J . C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci. 2000; 113 Pt 21:3737-45. DOI: 10.1242/jcs.113.21.3737. View